Psychemedics Corporation (PMD): Investing In Hair Detection

[Ed. Note – This article does not meet our new editorial guidelines, nor does the company profiled meet our investment criteria. Both will be removed from the site in the future.]

Psychemedics Corporation (NASDAQ:PMD) is a Boston-based drug testing services company that detects abused substances by analyzing hair samples. Its technology provides quantitative details about the approximate amount of drug taken along with historical data.… Read more

VST Tillers Tractors (India) – Global Agricultural Growth Story

[Ed. Note – This article does not meet our new editorial guidelines, nor does the company profiled meet our investment criteria. Both will be removed from the site in the future.]

VST Tillers Tractors Limited (BSE:531266, NSE:VSTTILLER), a mid cap company (Rs 3028M), promoted by VST Group and a joint venture with Mitsubishi Heavy Industries (OTC: MHVYF) and Mitsubishi Corporation of Japan, in 1967.… Read more

Tata Investment Corporation, a Safe Haven for Cautious Investors

[Ed. Note – This article does not meet our new editorial guidelines, nor does the company profiled meet our investment criteria. Both will be removed from the site in the future.]

Tata Investment Corporation Limited (BSE:501301, NSE:TATAINVEST), a midcap investment company (market cap 24050M Rupees), promoted by the well known Tata Group in India, has been a consistent performer for  more than two decades, with an unbroken record of dividend payments and  growing net asset value of investments.… Read more

Swaraj Engines Ltd, the supplier of M&M and SML ISUZU, announces a generous dividend

[Ed. Note – This article does not meet our new editorial guidelines, nor does the company profiled meet our investment criteria. Both will be removed from the site in the future.]

(Source: www.bseindia.com, and company press release)

Swaraj Engines Ltd. (BSE:500407), manufacturer of tractor engines for Mahindra & Mahindra, and high- tech  components for  SML ISUZU, recently announced a huge dividend of 330% for fiscal year 2012 – 2013.… Read more

Ajanta Pharma Reports Improvement

[Ed. Note – This article does not meet our new editorial guidelines, nor does the company profiled meet our investment criteria. Both will be removed from the site in the future.]

Ajanta Pharma (BSE:532331) is a midcap (market cap around 18190 million rupees) specialty pharmaceutical, multinational Indian company engaged in the research, development, production and marketing of pharmaceutical products. The products are marketed in more than 30 countries, including US and Europe. … Read more